Update
$Cybin(CYBN.US$ Cybin Announces Grant of Additional U.S. Patent in Support of Its Cyb003 Breakthrough Therapy Program for Major Depressive Disorder. Cybin Inc - to Commence Enrollment for a Multinational, Multisite Phase 3 Program Evaluating Cyb003 in Major Depressive Disorder Around Mid-Year 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
